// App-Quantinova.ai

: APPA, a potential new therapy for osteoarthritis, inhibits neutrophil pro-inflammatory functions without impairing host defence

Researchers

Presenter

  • A. Cross

Principal Investigators

  • J. Hawkes

  • H. Wright

  • N. Larkins

  • S. Edwards

  • R. Moots

Medical Centers

  • LIVERPOOL Univ., LIVERPOOL, United Kingdom

  • AKL RESEARCH & DEVELOPMENT, STEVENAGE, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoarthritis

Biomarkers

  • Proto-oncogene tyrosine-protein kinase ROS

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved